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Factors Influencing calcitriol metabolism in renal failure. Metabolic
clearance rate (MCR) and production rate (PR) of calcitriol is decreased
in experimental renal failure. In this experiment, we studied uremia and
secondary hyperparathyroidism as possible causes of the abnormal
calcitriol metabolism. Normal rats were made uremic by infusing
phosphorus-free urine for 24 hours. Both the MCR (0.22 0.01
mi/mm/kg, N = 6 P <0.001) and the PR (16.6 1.97 nglkg/day, P <
0.01) of calcitnol were significantly suppressed in normal rats following
urine infusion when compared to saline infused rats (MCR, 0.30 0.01;
PR, 32.9 4.1, N = 6). Different levels of protein intake by rats with
renal failure produced by subtotal nephrectomy also alter the PR but
not the MCR of calcitriol. Thus, the synthesis of calcitriol was signifi-
cantly lower in rats with renal failure fed a high protein (50% protein)
diet (17.6 0.7 ng/kg/day, N 8, P < 0.001) than in rats with renal
failure fed a normal protein (20% protein) diet (22.2 1.4, N = 7).
Thyroparathyroidectomy (TPTX) did not alter the MCR of calcitriol in
renal failure, even though parathyroid hormone, which may suppress
the degradation enzyme, could be elevated in this model of renal failure.
The MCR of TPTXed rats with renal failure (0.15 0.01 mI/mm/kg, N
= 7) remained lower than that of the TPTXed control rats (0.19 0.01,N = 7, P < 0.001), and chronic infusion of PTH to TPTXed rats with
renal failure did not change the MCR of calcitriol (0.15 0.01, vs.
control, 0.24 0.01). We conclude that urine contains factors which
inhibit calcitriol metabolism, and secondary hyperparathyroidism is not
responsible for the decreased MCR in renal failure.
Previous studies from our laboratory have demonstrated that
the production rate (PR) and metabolic clearance rate (MCR) of
calcitriol are decreased in experimental renal failure [1]. The
reason for which the MCR decreases in renal failure is not
entirely clear. In partially nephrectomized rats we have shown
by linear regression analysis that the MCR of calcitriol posi-
tively correlates with the creatinine clearance [I]. This relation-
ship suggests that the decreased MCR after partial nephrectomy
is due to suppression of calcitriol degradation enzymes by a
substance(s) in uremic plasma or removal of enzymes in the
kidney responsible for the degradation of calcitriol. Subse-
quently we found that MCR of calcitriol is suppressed in normal
rats made uremic by urine reinfusion [2]. In the latter experi-
ment, the animals also developed acidosis, hyperphosphatemia,
and hypocalcemia. Since calcium [3, 4], phosphorus [5, 6] and
acidosis [7, 8] are known to influence calcitriol metabolism, it
was not clear whether the suppression of calcitriol metabolism
was caused by uremia or by other metabolic abnormalities. In
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this experiment, we studied the effect of uremia on calcitriol
metabolism in normal rats made uremic by infusion of phos-
phorus-free urine. Although acidosis, hyperphosphatemia and
hypocalcemia did not develop in these animals, we found
suppression of the calcitriol PR and MCR presumably caused
by substances in the urine.
Since uremic toxins could be responsible for abnormal cal-
citriol metabolism and most of these toxins are believed to be
the metabolic products of ingested protein, we also studied the
effects of different levels of protein intake on calcitriol metab-
olism in rats with renal failure.
Finally, parathyroid hormone is reported to suppress the
degradation enzyme of calcitriol [9, 10]. Its level could be
elevated in this model of renal failure, therefore, the effects of
thyroparathyroidectomy on the MCR of calcitriol were investi-
gated in rats with renal failure.
Methods
Male Sprague-Dawley rats were used throughout this exper-
iment. On the day of experimentation, the rats were weighed
and anesthetized with ether. Both the femoral artery and vein
were cannulated with polyethylene tubing for blood sampling
(through femoral arterial catheter) and fluid infusing (through
femoral veins). A PE tube was inserted into the bladder for
urine collection. The animals were placed in individual meta-
bolic cages and allowed to awaken before the experiment. The
MCR of calcitriol was determined by the constant infusion
method [1]. Radioactive calcitriol [1 a,25,(3H-26,27)-dihydroxy-
vitamin D3, specific activity 160 Ci/mmol and 96% purity in
ethanol] was mixed with 0.5 ml of rat plasma and diluted with a
sufficient volume of normal saline. The solution was infused
intravenously into fasting animals at a rate of 0.0025 ml/min/l00
g. Approximately 0.0025 MCi/hr radioactive calcitriol was in-
fused for 19 hours. The total amount of radioactive tracer
infused was approximately 2% of the estimated endogenous PR
of calcitriol in a normal rat. Blood samples (0.5 ml) were
withdrawn 17 hours and 19 hours after the infusion was begun
and centrifuged immediately to separate the RBC from plasma.
The RBCs were mixed with equivalent volumes of pooled rat
plasma and returned to the rats. The plasma was stored
immediately at —20°C until the amount of radioactive calcitriol
was determined. Coefficients of variation for the plasma tracer
measurements at 17 and 19 hours averaged 5.8%. The plasma
concentrations of tracer reached a steady state after 17 hours of
infusion, and the mean MCR determined at 17 and 19 hours
were not different for each group of animals. Therefore, only
the average values of 17 and 19 hours are presented in this
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study. The experiments were performed with the approval of
institutional animal care and use committee.
The plasma level of radioactive calcitriol was determined by
a method described in previous publications [1, 11]. Briefly, 200
ml of thawed plasma were brought to 1 ml by the addition of
normal saline. Cold calcitriol, 300 ng in 40 pi absolute ethanol,
was added to monitor recovery. Plasma protein was precip-
itated using I ml of acetonitrile followed by vigorous vortexing
and centrifugation. The supernatant was combined with 0.5 ml
K2HPO4 (0.4 M, pH 10.6) and applied to a LC-l8 column. The
column was eluted with 5 ml of distilled water, 3 ml of 70%
methanol and 6 ml of acetonitrile. The last fraction, containing
vitamin D metabolites, was dried under nitrogen. The residue
was dissolved in 500 d of HPLC solvent containing 88%
hexane, 10% isopropanol, and 2% methanol. Radioactive cal-
citriol was separated from the other metabolites using an HPLC
solvent delivery system (Spectra Physics SP 8710, San Jose,
California, USA). Calcitriol recovery averaged 69%. We have
demonstrated that the straight phase HPLC system separated
calcitriol from 1 ,24,25(OH)3D3, calcitroic acid, and 1,25,26
(OH)3D3. Furthermore, the peak of radioactivity comigrating
with calcitriol on straight phase HPLC eluted as a single
radioactive peak that coeluted with standard calcitriol on a
reverse phase system (20% water in methanol) using a S m
C-l8 analytical column with excellent recovery [121. The mobile
phase used in this study is also reported to separate calcitriol
from 1,25(OH)2D3, 26,23-lactone, 1,23,25(OH)3D3, 24-oxo-l,25
(OH)2D3, 23-oxo-1 ,25(OH)2D3, 24-oxo-1 ,23,25(OH)3D3, and
other vitamin D metabolites [13]. Our intra-assay and interassay
coefficients of variation of radioactive calcitriol were 6.8% and
6.7% (N = 6), respectively.
The MCR of calcitnol is calculated as follows:
CR —
infusion rate of 3H-calcitriol
—
the mean steady-state plasma concentration of 3H-calcitriol
The PR of calcitriol is calculated as:
PR = MCR x endogenous plasma concentration of calcitriol
Effect of uremia on calcitriol metabolism in normal rats
Sprague-Dawley rats weighing 230 to 260 g were fed Purina
rat chow prior to the study. The effect of uremia on calcitriol
MCR was assessed by urine infusion for 24 hours. Urine was
collected overnight from fasted normal rats in individual meta-
bolic cages, centrifuged at 20,000 g for 40 minutes to precipitate
bacteria, and mixed with zirconium oxide (Organon Teknika,
Oklahoma, Oklahoma, USA) to remove inorganic phosphorus
(100 mg to 1 ml urine) [14]. We have confirmed that zirconium
oxide removes more than 99% of inorganic phosphorus, as
previously reported [14], by acting as an anion exchanger which
binds phosphorus and releases acetate. The urine osmolality
was adjusted to 400 mOsm/kg H2O by adding distilled water,
and the urine pH was adjusted to 7.40. The final urine contained
Na 31 mEq/liter, K 50 mEq/liter, and urea 6.7 mg/ml. A portion
of this phosphorus-free urine was additionally filtered through a
dialyzer (CA 50, CAM Cellulose Acetate Hollow Fiber Dia-
lyzer, Travenol Laboratory Inc., Deerfield, Illinois, USA)
which excludes substances with molecular weights greater than
approximately 10,000 daltons (personal communication with
Travenol Laboratory engineer). The ultrafiltration rate was
Table 1. Composition of diets
20% Protein 50% Protein
g/kg
Casein
Sucrose
Cornstarch
Corn oil
Cellulose
Vitamin mix
(Teklad 40060)
Vitamin D3
Ca
P
Na
K
Mg
230.0
457.2
150
50
50.0
10.0
0.0046
10.2
7.8
1.0
3.77
0.5
575.0
161.2
150
46.6
14.7
10.0
0.0046
10.2
7.8
1.0
3.77
0.5
approximately 30 mllmin at a urine flow rate of 200 mi/mm
pumped with a Cobe dialysis pump. The estimated transmem-
brane pressure during ultrafiltration was approximately 400 mm
Hg (maximum transmembrane pressure suggested for the dia-
lyzer is 500 mm Hg).
The effects of uremia on calcitriol metabolism were studied as
follows: Group I (N 6) rats were infused for 24 hours with
normal saline solution containing urea (final osmolality 410
mOsm/kg H2O). The concentration of urea in the saline was
equivalent to that of pooled rat urine (6.7 mg/ml). The total
volume infused into the rats was 70 to 100 ml. Group 2 (N =6)
rats were infused for 24 hours with 70 to 100 ml of phosphorus-
free urine ultrafiltrate. Group 3 rats (N = 6) were infused for 24
hours with 70 to 100 ml of ultrafiltrate of urine. Radiolabelled
calcitriol was infused starting at five hours after urine or saline
infusion, and the isotope was infused for 19 hours. The MCR
and PR of calcitriol were measured 24 hours after urine or saline
infusion. Arterial blood was taken for measurement of hemato-
crit, total plasma calcium, ionized calcium, phosphorus, urea
nitrogen, Na, K, creatinine, pH, pCO2 and endogenous plasma
concentration of calcitriol. Urine was collected for volume
measurement after the urine or saline infusion.
Effect of protein intake on calcitriol metabolism
Sprague-Dawley rats weighing 200 g were subjected to sub-
total nephrectomies or sham nephrectomies through bilateral
flank incisions. One kidney was removed, and two-thirds of the
other kidney was resected as described previously [1]. Animals
were divided into three groups as follows: Group 1 animals (N
= 8) had sham operation for nephrectomies and were fed a 20%
protein diet. Group 2 animals (N = 7) had subtotal nephrecto-
mies and were fed a 20% protein diet. Group 3 animals (N 8)
had subtotal nephrectomies and were fed a 50% protein diet. All
the animals were fed the respective diets for three weeks. Since
rats fed 50% protein diet ingested less, feeding of the other two
groups of rats was paced according to the intake of this group.
The diets (Teklad Test Diets, Madison, Wisconsin, USA) were
isocaloric and contained identical quantities of calcium (1.0%),
phosphorus (0.8%), sodium chloride, and potassium as well as
other minerals, and vitamins (Table 1).
The MCR and PR of calcitriol were measured in the three
groups of rats after they were on the diets for three weeks.
Arterial blood was obtained for determination of calcium,
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phosphorus, pH, pCO2, BUN, creatinine, and calcitriol. Urine
was collected for creatinine clearance during the measurement
of MCR.
Effect of PTH on calcitriol metabolism
Sprague-Dawley rats weighing approximately 200 g were
used in this study. Renal failure was achieved by subtotal
nephrectomy through bilateral flank incisions. Control animals
had sham nephrectomies. Two weeks after subtotal nephrec-
tomy or sham operation, all animals had total thyroparathyroid.
ectomies (TPTX). Before TPTX and 24 and 72 hours after
TPTX, 0.5 ml of heparinized blood was withdrawn from the tail
vein for total plasma calcium and phosphate determinations.
Total plasma concentrations of calcium in all the animals
studied had decreased more than 2 mgldl after TPTX. Calcitriol
metabolism in both control and experimental rats was studied
three weeks later.
Since TPTX may result in greater phosphate retention in
renal failure rats with secondary hyperparathyroidism, in com-
parison to control rats, both control and experimental rats were
fed a 0.2% phosphorus diet, which also contains 1% Ca, and 4,5
IU/g vitamin D, for one week immediately after TPTX. The
0.2% phosphate diet is an optimal diet for growing rats, and
urinary phosphate excretion was nearly undetectable when the
rats were fed with this diet [15]. Since urinary phosphate was
completely preserved in both TPTXed normal rats and TPTXed
rats with renal failure fed with this diet, decreased glomerular
filtration would no longer cause greater phosphate retention in
TPTXed rats eating this low phosphorus diet. In addition, each
animal received a subcutaneous injection of 4 tg L-thyroxine
(Levotyroid, Armour Pharmaceutical Co., Kankabee, Illinois,
USA) every other day after TPTX [16]. Animals were divided
into two groups as follows:
Calcitriol metabolism in renal failure rats without parathy-
roid hormone supplementation. The MCR and PR of calcitriol
were measured one week after TPTX in both control (N = 7)
and renal failure (N = 7) rats by the constant infusion method
described above. At the end of the isotope infusion, arterial
blood was obtained for determination of total plasma calcium,
ionized calcium, phosphorus, pH, pCO2, creatinine and cal-
citriol. Urine was collected during the isotope infusion for
creatinine measurement. Creatinine clearance was calculated
using the standard formula.
Calcitriol metabolism in renal failure rats with parathyroid
hormone supplementation. Twenty-four hours after successful
TPTX, both control (N = 6) and renal failure (N = 5) rats were
continuously infused subcutaneously for one week with bovine
PTH (Sigma Co., St. Louis, Missouri, USA), 0.8 U/hr, deliv-
ered by Alza osmotic minipump implanted subcutaneously in
the interscapular space (Model 2001, Alzet, Palo Alto, Califor-
nia, USA). The dose of PTH placed in the osmotic minipump
was calculated according to the daily endogenous PR in normal
rats [17]. PTH was dissolved in a solution containing 2%
cysteine, 1 mM HCI, and 0.9% saline to prevent the loss of its
biologic effect [18]. The MCR and PR of calcitriol were mea-
sured one week after P1'H infusion. Arterial blood samples
were obtained at the end of 3H-calcitriol infusion for plasma
determination of total calcium, ionized calcium, phosphorus,
creatinine, pH, pCO2 an calcitriol concentration. Urine for
creatinine measurement was collected throughout the isotope
infusion for creatinine measurement.
Analytical methods
Calcium was measured by atomic absorption spectropho-
tometry (Model 306, Perkin Elmer, Norwalk, Connecticut,
USA). Phosphorus and creatinine concentrations were deter-
mined as previously described [19]. Urea nitrogen was mea-
sured by the urease method. Ionized calcium, Na and K were
measured by a NOVA Model 6 calcium electrode (NOVA
Biomedical, Newton, Massachusetts, USA). The blood pH and
pCO2 level were measured by an IL 713 pH/blood gas analyzer
(Instrumentation Lab Inc., Lexington, Massachusetts, USA).
Plasma calcitriol was measured in duplicate using commercial
radioreceptor assay kits (Immuno Nuclear, Stillwater, Minne-
sota, USA) according to the methods of Reinhardt et al [11].
Our interassay coefficients of variation were 7.0% for low
control (20 pg/mI, N 12) and 4.1% for high control (100 pg/ml,
N = 12). Calcitriol recovery averaged 67 to 75%. Calcitriol was
undetectable in water blanks.
All data are expressed as mean SEM. Statistical analysis
was performed using the Student t-test for two groups of data
analysis, and Duncan's multiple range test [20] was used for
multiple comparison.
Results
Effect of uremia on calcitriol metabolism in normal rats
The effect of urine infusion and saline-urea infusion on
plasma concentrations of calcium, phosphorus, and electrolytes
of normal rats are shown in Table 2. Plasma concentrations of
urea nitrogen were equally elevated among the three groups of
animals. Plasma concentrations of creatinine were significantly
higher in the urine infused rats as expected. Blood pH and pCO2
were not different among the three groups. The total volumes of
fluid infused to the three groups of rats were similar. The urine
output matched the fluid infused to each group of animals, and
hematocrits were similar among the three groups of animals at
the end of infusion (I, 41.0 1.13%; II, 41.4 0.68; III, 42.5
0.62, P = NS).
The results of calcitriol metabolism following urine infusion
are presented in Table 3. The MCRs of calcitriol were signifi-
cantly suppressed in normal rats infused with either phospho-
rus-free urine or ultrafiltrate of urine. Plasma concentrations of
calcitriol of rats infused with phosphorus-free urine were sig-
nificantly lower than those of control rats infused with saline.
The levels, however, did not differ between rats infused with
ultrafiltrate of urine and rats infused with saline. The calculated
PRs of calcitriol were significantly lower in both groups of rats
infused with phosphorus-free urine and ultrafiltrate of urine, in
comparison to the control rats infused with saline.
Effect of protein intake on calcitriol metabolism in renal
failure
Table 4 summarizes renal functions, plasma concentrations
of calcium and phosphorus, and calcitriol metabolism. Renal
functions were decreased in subtotally nephrectomized rats,
but they were not different between the rats fed 20% and 50%
protein diets. Plasma concentrations of calcium and phospho-
rus, and blood pH (Group 1,7.42 0.01; Group II, 7.41 0.01;
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Table 2. Plasma concentration of creatinine, urea nitrogen, calcium, phosphorus, electrolyte, pH, pCO2, and volume of urine infused, and
volume of urine excreted by rats infused with urine
B d
g
SCr BUN Ca 'Ca P 'Na
mEqlliter pH
c
'mmt
Hg
Urine
volume
infused
Urine
volume
excreted
Isotope
fluid
infused
mlmg/d liter
Group 1N=6
Group 2
N—6
Group 3N=6
245
245
243
0.49
1.82
1.89
71.0
72.0
71.5
9.77
9.62
9.68
4.65
4.70
4.66
7.77
7.73
7.80
146.2 4.12
147.2 4.65
146.0 4.22
7.42
7.44
7.44
36.8
33.2
36.3
86.8
85.7
98.5
92.7
96.3
106.8
6.95
6.90
6.73
Comparisons
1-2
1-3
2-3
NS
NS
NS
<0.001
<0.001
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS NS
NS NS
NS NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
Group 1, saline-urea infused rats; Group 2, zirconium-treated urine infused rats; Group 3, ultrafiltrate of urine infused rats. Abbreviations are:
Scr, serum creatinine; BUN, blood urea nitrogen; 1Ca and Pa+*, total plasma and ionized Ca; plasma phosphorus; DNa, plasma sodium; K,
plasma potassium. Statistical analysis was made by analysis of variance and Duncan's multiple ranking test. A P value of less than 0.05 was
considered significant.
Table 3. Plasma concentration of calcitriol, and production rate and
metabolic clearance rate of calcitriol in urine infused rats
Plasma
calcitriol
pg/rn!
PR
ng/kg/day
MCR
mi/mm/kg
Group 1 75.3 8.64 32.9 4.1 0.30 0.006
N= 6
Group 2 51.6 6.0 16.6 1.97 0.22 0.007
N= 6
Group 3 69.1 3.5 23.5 1.05 0.22 0.006
N= 6
Comparisons
1-2 <0.05 <0.001 <0.001
1-3 NS <0.05 <0.001
2-3 NS NS NS
Abbreviations are: Group 1, saline-urea infuse rats; Group 2, phos-
phorus-free urine infused rats; Group 3, ultrafiltrate of urine infused
rats. MCR, metabolic clearance rate; PR, production rate. Statistical
analysis was made by analysis of variance and Duncan's multiple
ranking test. A P value of less than 0.05 was considered significant.
Group III, 7.42 0.01) and pCO2 (Group I, 33.1 1.1 mm Hg,
Group II, 35.9 1.4, Group III, 33.5 1.5) were not different
among the three groups of animals. BUN were highest in Group
3 rats, and they were also elevated in Group 2 animals as
expected. In spite of similar daily ingestion of diets, body
weights were lower in rats with renal failure (average dietary
intake, Group 1, 21.1 1.3 glday; Group 2, 21.6 0.04; Group
3, 20.5 0.08; P = NS).
The MCRs and PRs of calcitriol were decreased in both
groups of renal failure rats when compared to those of sham-
operated controls. Ingestion of high protein diet did not alter the
MCR in rats with renal failure; however, it suppressed the PR of
calcitriol and thereby lowered the plasma concentrations of
calcitriol (Table 4).
Effect of parathyroid hormone on calcitriol metabolism in
renal failure
Parathyroidectomy without parathyroid hormone supple-
mentation. Table 5 summarizes the renal functions, plasma
concentration of calcium and phosphorus, and calcitriol metab-
olism in animals with TPTX. The body weight of control
animals was significantly greater than that of rats with renal
failure. Creatinine clearance of nephrectomized rats decreased
to approximately 33% of control animals. Plasma concentra-
tions of calcium were deceased and those of phosphorus were
increased markedly 24 and 72 hours after TPTX in both groups
of animals; however, these values did not differ between control
rats and rats with renal failure (these data are not presented in
the Table).
The MCRs of rats with renal failure were markedly reduced,
and their plasma concentrations of calcitriol were not different
from those of control animals. The calculated PRs of calcitriol
of rats with renal failure did not differ from those of the
controls. Plasma concentrations of total calcium, ionized cal-
cium and phosphorus levels as well as blood pH (sham control,
7.40 0.01; 5/6 nephrectomy, 7.40 0.01) and pCO2 (sham,
35.4 2.04 mm Hg; 5/6 nephrectomy, 34.7 2.1) at the time of
MCR measurements were similar between the two groups of
animals (Table 5).
Parathyroidectomy with parathyroid hormone supplementa-
tion. Table 6 shows the renal function, plasma levels of calcium
and phosphorus, and calcitriol metabolism in TPTXed rats with
parathyroid hormone replacement. Rats with renal failure
weighed significantly less than the control rats, and their
average renal functions decreased to 37% of the control rat
renal function after subtotal nephrectomy. In both control rats
and rats with renal failure 24 hours after TPTX, plasma con-
centrations of calcium were decreased and phosphorus levels
were increased. However, both plasma concentrations of cal-
cium and phosphorus were restored to the pre-TPTX values 48
hours after replacement of PTH (data are not presented in the
Table).
The MCRs of renal failure rats remained lower than those of
controls. Plasma concentrations of calcitriol, as well as the
calculated PR of calcitriol, were not different between control
and renal failure rats. Plasma concentrations of calcium, phos-
phorus, pH (sham, 7.40 0.01; 5/6 nephrectomy, 7.39 0.01)
and pCO2 (sham, 38.6 1.65 mm Hg, 5/6 nephrectomy, 35.1 ±
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Table 4. Plasma concentrations of calcium and phosphorus, renal function, and calcitriol metabolism in renal failure rats fed
with different protein diets
Body
wt
g
WTN Cr
mg/dl
C
ml/min/lOO g
Ca PCa PF Plasmacalcitriol
pg/mi
PR
ng/kg/day
MCR
mi/mm/kgmg/dl
Group 1
Sham control 273.1 20.3 0.52 0.53 9.83 4.67 7.14 87.6 31.3 0.25
20% protein 8.9 0.8 0.01 0.02 0,12 0.05 0,16 4.0 1.5 0.01N=8
Group II
5/6 Nephrectomy 259.7 66.3 1.32 0.15 9.80 4.65 6.73 91.4 22.8 0.17
20% protein 10.8 1.5 0.03 0.01 0.11 0.03 0.15 5.3 1.6 0.01N7
Group III
5/6 Nephrectomy 225.3 106.0 1.34 0.15 9.89 4.70 7,23 69.1 17.6 0.18
50% protein 6.1 4.3 0.02 0.01 0.13 0.04 0.16 2.6 0.67 0.01
N= 8
Comparisons
I-LI NS <0.001 <0.001 <0.001 NS NS NS NS <0.001 <0.001
I-Ill <0.001 <0.001 <0.001 <0.001 NS NS NS <0.005 <0.001 <0.001
Il-Ill <0.01 <0.001 NS NS NS NS NS <0.001 <0.01 NS
Abbreviations are in Table 2.
Table 5. Production and degradation of calcitriol, and plasma concentrations of calcium and phosphorus of TPTXed renal failure
and control rats
Body
wt
g
Cc,.
ml/min/IOO g
'Ca Plasmacalcitriol
pg/mi
PR
ng/kg/day
MCR
mllmin/kgmg/di
Sham control 249 0.46 5.00 2.01 12.00 93.30 25.6 0.19N = 7 10.7 0,03 0.07 0.09 0.41 14.6 4.3 0.01
5/6 Nephreetomy 200 0.15 4.97 2.01 12.20 112.3 24.6 0.15
N = 7 11.5 0.02 0.18 0.06 0.52 10 3.3 0.01
P value <0.001 <0.001 NS NS NS NS NS <0.001
Abbreviations are in Table 2.
Table 6. Production and degradation of calcitriol, and plasma concentrations of calcium and phosphorus of TPTXed renal failure and control
rats supplemented with parathyroid hormone
Body
wt
g
Ce,.
ml/min/iOO g
PCa PP PCa Plasmacalcitriol
pg/mi
P
ng/kg/day
MCR
mi/mm/kgmg/dl
Sham control 238 0.52 9.83 5.92 4.31 86.9 28.4 0.24N 6 15.7 0.03 0.09 0.20 0.10 16.2 3.7 0.01
5/6Nephrectomy 192 0.19 9.84 5.60 4.48 105.5 22.5 0.15N = 5 8.4 0.03 0.08 0.09 0.04 17.6 3.4 0.01
P value <0.001 <0.001 NS NS NS NS NS <0.001
Abbreviations are in Table 2.
2.15) measured at the end of MCR study were comparable for
the two groups of animals.
Discussion
The conversion of 25-hydroxyvitamin D3 to calcitriol by the
enzyme, lit-hydroxylase, occurs primarily in the kidney [21],
and the conversion is normally the rate limiting step in the
production of calcitriol. The decreased production of calcitriol
in renal failure, therefore, can be attributed to loss of renal mass
and la-hydroxylase, and suppression of la-hydroxylase activ-
ity by the retention of phosphate [5] and metabolic acidosis [7,
8]. In the present study, we have shown that urine contains
substances that also suppressed the metabolic production of
calcitriol. Infusion of the urine was not associated with meta-
bolic acidosis or hyperphosphatemia. The factors which were
responsible for the suppression of MCR and PR of calcitriol
could diffuse through the hollow fiber dialyzer.
Since most uremic toxins are believed to be the metabolic
products of ingested protein [22, 23], we studied the effects of
different levels of protein intake on the calcitriol metabolism.
Diets were adjusted to be isocaloric and to contain identical
mineral and electrolyte content. High protein diet significantly
suppressed the synthesis of calcitriol in renal failure rats. High
protein intake is known to increase plasma concentrations of
guanidinosuccinic acid (GSA) in patients with chronic renal
failure [24], therefore, possible suppression of calcitriol synthe-
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sis by GSA was recently investigated (unpublished observa-
tion). Infusion of GSA (1.8 mg/dl, 10 ml, a concentration similar
to that of hemodialysis patients, 2.32 1.41 mg/dl [25]) for 24
hours to normal rats markedly suppressed the PR of calcitriol.
Therefore, the lower PRs of calcitriol in renal failure rats fed
with high protein diet could be partly due to the elevation of
GSA. It should be noted that the decreased production of
calcitriol in this group of rats cannot be attributed to a change in
the renal function by ingestion of high protein diet, since their
creatinine clearance did not differ from those of renal failure
rats fed a 20% protein diet. Phosphate intake which is known to
modulate calcitriol synthesis [SI was kept identical in this
experiment.
We have also demonstrated that the MCRs of calcitriol were
suppressed in normal rats made uremic by urine infusion. This
study indicates that urine contains substances which inhibit the
degradation enzymes of calcitriol. The inhibitory factors could
also be present in the plasma of rats with renal failure. Although
much is known about the factors regulating the synthesis of
calcitriol, little is known about its degradation. The kidney is
capable of converting calcitriol to I ,24,25-trihydroxyvitamin D3
[26]. However, the conversion of calcitriol to the trihydroxy
metabolite is not reduced in anephric animals, suggesting that
most 24-hydroxylation occurs extrarenally [27, 28], possibly in
intestine which also contains 24-hydroxylase [28]. In addition,
calcitriol is metabolized by side-chain cleavage to calcitroic
acid just as efficiently in anephric rats as in normal rats [29, 30].
Since 24-hydroxylation and side-chain cleavage of calcitriol can
occur in anephric animals, uremia must suppress degradation of
calcitriol through another metabolic pathway. A recent study
has suggested that C-23 oxidation of calcitriol could be a major
pathway for calcitriol metabolism [31]. It remains to be dem-
onstrated that this oxidative pathway can be suppressed by
uremia.
A recent study indicated that MCR of calcitriol is not
decreased in dogs with moderate and severe renal failure [32].
PR of calcitriol is decreased in dogs with severe renal failure,
but not in dogs with moderate renal failure. The reasons of the
discrepancy between this study and ours are not entirely clear.
It is possible that the potentially lower MCR in dogs with renal
failure could be disclosed, if these animals were provided with
excessive amount of calcitriol. Under such a stressed condition,
one may find the differences of MCR between normal dogs and
dogs with renal failure.
Parathyroid hormone may regulate the MCR of calcitriol
through its suppression of the activity of 24-hydroxylase [10,
33]. The 24,25-dihydroxyvitamin D3 production was decreased
when kidney cell cultures were incubated with parathyroid
hormone [33]. However, the study was not always reproducible
[33]. The elimination rate of calcitriol has been reported to be
normal in human hypoparathyroidism [34]. In this study, the
tritiated calcitriol was not separated from other vitamin D
metabolites using HPLC. Therefore, the results must be inter-
preted with caution. In contrast, we have shown that TPTXed
rats with normal renal function tend to have lower MCRs (0.19
mllminlkg) than do rats supplemented with PTH (0.24 ml!
mm/kg).
In the present study, we have assessed the influence of
secondary hyperparathyroidism on calcitriol metabolism, as the
PTH level could be elevated in this model of renal failure [35].
The MCRs of TPTXed rats with renal failure remained lower,
and replacement of PTH did not alter the MCRs in this study
group; therefore, these studies suggest that secondary hyper-
parathyroidism, if present, cannot be responsible for the de-
creased MCR in rats with renal failure.
Plasma concentrations of calcitriol have been reported to be
lower in human hypoparathyroidism [36] and in parathyroidec-
tomized rats fed a normal phosphorus diet (1.1% Ca and 0.8%
P) [37], when compared to normal subjects and sham-operated
rats, respectively. However, when the parathyroidectomized
rats were fed for one week on a low phosphorus diet identical to
the one used in this study, the plasma levels of calcitriol did not
differ from that of sham-operated control rats fed the same diet
[37]. Since plasma level of calcitriol is determined not only by
its production but also by its degradation, the decreased MCR
of calcitriol in TPTXed rats with intact kidney (0.19 vs. 0.24, P
<0.01) could mostly account for the absence of lower levels of
calcitriol when compared to the TPTXed rats which received
PTH (Tables 5 and 6). Further, the differences in PRs of
calcitriol were abolished between TPTXed and nephrectomized
rats and TPTXed control rats with or without PTH replacement
when these animals were fed with phosphate restricted diet.
Dietary phosphate restriction results in greater variability in
plasma levels of calcitriol. Additional studies are needed to
investigate how phosphate restriction abolishing the differences
in PRs between control rats and rats with renal failure.
In summary, we have confirmed our previous findings that
the MCR of calcitriol is decreased in renal failure produced by
partial nephrectomy. Secondary hyperparathyroidism, if pre-
sent, is not responsible for the decreased MCR in this model of
renal failure. Synthesis of calcitriol is suppressed in rats with
renal failure fed a high protein diet. Finally, we have provided
evidence that urine contains inhibitory factors which suppress
both the MCR and the PR of calcitriol, and the substances
responsible for the abnormal calcitriol metabolism, if present in
the uremic plasma, are dialyzable through hollow fiber dialyzer.
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